180 related articles for article (PubMed ID: 160840)
21. [Subacute myelopathy during a course of treatment with clioquinol in a patient colectomized for Crohn's disease].
Fabiani F; Pompili A; Scarinci A; Sinibaldi L
Riv Neurobiol; 1978; 24(1-2):121-37. PubMed ID: 161413
[No Abstract] [Full Text] [Related]
22. Peripheral neuropathy in rats fed with clioquinol.
Jones EL; Searle CE; Smith WT
J Pathol; 1972 Jul; 107(3):P8-9. PubMed ID: 4263803
[No Abstract] [Full Text] [Related]
23. Zinc deficiency, acrodermatitis enteropathica, optic atrophy, subacute myelo-optic neuropathy, and 5,7-dihalo-8-quinolinols.
Sturtevant FM
Pediatrics; 1980 Mar; 65(3):610-3. PubMed ID: 6444713
[TBL] [Abstract][Full Text] [Related]
24. Is there SMON in India?
Wadia NH
Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
[No Abstract] [Full Text] [Related]
25. Data on clioquinol and S.M.O.N.
Lee JA
Lancet; 1978 Sep; 2(8092 Pt 1):738. PubMed ID: 80663
[No Abstract] [Full Text] [Related]
26. Data on clioquinol and S.M.O.N.
Shigematsu I; Yanagawa H
Lancet; 1978 Oct; 2(8096):945. PubMed ID: 81960
[No Abstract] [Full Text] [Related]
27. [The history of quinolines].
Wolffers I
Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1246-9. PubMed ID: 3160957
[No Abstract] [Full Text] [Related]
28. Clioquinol intoxication occurring in the treatment of acrodermatitis enteropathica with reference to SMON outside of Japan.
Hanakago R; Uono M
Clin Toxicol; 1981 Dec; 18(12):1427-34. PubMed ID: 6460590
[TBL] [Abstract][Full Text] [Related]
29. SMON and other socially induced diseases in Japan.
Sonoda K
Soc Sci Med (1967); 1978 Nov; 12(6A):497-506. PubMed ID: 153585
[No Abstract] [Full Text] [Related]
30. Idiosyncratic neurotoxicity: clioquinol and bismuth.
Lancet; 1980 Apr; 1(8173):857-8. PubMed ID: 6103216
[No Abstract] [Full Text] [Related]
31. Clioquinol and S.M.O.N.: Reanalysis of original data.
Asao M
Lancet; 1979 Feb; 1(8113):446. PubMed ID: 84300
[No Abstract] [Full Text] [Related]
32. [Subacute myelo-optico-neuropathy].
Folgerø B; Gundersen SG; Sigstad H
Tidsskr Nor Laegeforen; 1982 Jun; 102(16):896-7. PubMed ID: 7164039
[No Abstract] [Full Text] [Related]
33. [Neurological complications in the course of treatment of acrodermatitis enteropathica with oxyquinoline derivatives].
Papuziński M; Wilmowska-Pietruszyńska A
Pediatr Pol; 1974 Nov; 49(11):1393-7. PubMed ID: 4278959
[No Abstract] [Full Text] [Related]
34. Chinese acupuncture treatment for SMON patients.
Katahira K; Kobayshi T; Higashida T; Kamae S; Nakajima Y; Fujimoto S
Chin Med J (Engl); 1986 Nov; 99(11):910-1. PubMed ID: 2953563
[No Abstract] [Full Text] [Related]
35. Neurotoxicity of oxyquinolines.
Hansson O; Herxheimer A
Lancet; 1980 Jun; 1(8180):1253-4. PubMed ID: 6104069
[No Abstract] [Full Text] [Related]
36. Clioquinol: time to act.
de Pinto O; Burley D
Lancet; 1977 Jun; 1(8024):1256. PubMed ID: 68347
[No Abstract] [Full Text] [Related]
37. [Serious sensory-motor neuropathy. A case of renal failure following clioquinol absorption].
Gendre JP; Barbanel C; Degos JD; Le Quintrec Y
Nouv Presse Med; 1974 Nov; 3(37):2395-8. PubMed ID: 4282135
[No Abstract] [Full Text] [Related]
38. [SMON--a model of the iatrogenic disease].
Takasu T
Rinsho Shinkeigaku; 2003 Nov; 43(11):866-9. PubMed ID: 15152488
[TBL] [Abstract][Full Text] [Related]
39. Relationship between neurological symptoms and concentrations of clioquinol in serum and nervous systems of beagle dogs.
Hayakawa K; Imanari T; Tamura Z; Kuroda S; Ikeda H; Tateishi J
Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2013-8. PubMed ID: 144569
[No Abstract] [Full Text] [Related]
40. Neurotoxicity of clioquinol in laboratory animals.
Tateishi J; Kuroda S; Saito A; Otsuki S
Lancet; 1972 Nov; 2(7786):1095. PubMed ID: 4117427
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
